Plain Facts compilation, we present to you data-based insights, with easy-to-read charts, to help you delve deeper into the ...

A former private sector executive with experience of handling major state-owned financial institutions and a long-time ...

Lured to Cambodia, tortured and forced to defraud strangers online, a Thai teenager said he barely survived after he threw ...

Asean members include Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam ...

Iran, Israel cease-fire gets off to a fragile start, Compass sues Zillow in real estate rift, nuclear firm Holtec could go ...

This biotech’s stock rockets on oral obesity-drug partnership with Wegovy parent Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which include GLP-1, for obesity and ...

Zepbound helped patients lose 50 pounds, compared to 33 pounds with Wegovy The study showed Zepbound users lost 20% of body weight Both drugs caused some mild stomach-related side effects MONDAY ...

For the primary endpoint, participants treated with Zepbound achieved an average weight reduction of 20.2% compared to 13.7% with Wegovy at 72 weeks using the treatment-regimen estimand, a 47% ...

MONDAY, May 12, 2025 (HealthDay News) — A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk’s Wegovy. The ...